Gentalyn 0.1% cream

Gentalyn is a well-known pharmaceutical brand specializing in dermatological treatments, specifically antibiotic creams containing gentamicin sulfate. Originally developed by the American pharmaceutical giant Schering-Plough, the brand has a significant history in the European market, particularly in Italy through its historical subsidiary, Essex Italia.

Following the major merger in 2009, Merck & Co. (known as MSD outside the U.S. and Canada) became the ultimate owner of the brand. Manufacturing for the Italian and European markets has traditionally been concentrated in specialized pharmaceutical facilities in Italy. Today, while ownership remains under the global Merck & Co. umbrella, the product is distributed via local entities such as MSD Italia, ensuring compliance with local healthcare regulations and standards.